OneChain’s CAR T trial treats its first cortical T-cell ALL patient
The subtype accounts for 20% of all T-cell leukaemias, a rare form of blood cancer which produces too many abnormal T-cells
Read More
Author: Jen Brogan
Johns Hopkins scientists depict molecular pathway to track replication in cancer cells
The findings could potentially lead to new therapies and could stop the growth of cancers
Read More
Chiesi and Gossamer collaborate to develop drug to treat respiratory diseases
Gossamer’s seralutinib is designed to treat pulmonary arterial hypertension and other indications
Read More
NHS to roll out fibre optic laser therapy to prevent seizures in epileptic patients
The chronic brain disease that causes seizures currently affects around 600,000 people living in the UK
Read More
Francis Crick Institute and Broken String Biosciences partner for ALS research
The rare and fatal progressive neurodegenerative disease is estimated to affect 5,000 people in the UK
Read More- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
- CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment
- FDA approves new high dose Spinraza regimen for SMA
